| Title | RNA sequencing of baseline tumor samples for exploring predictive biomarkers of Sintilimab plus chemo as first-line treatment in squamous non-small-cell lung cancer |
|---|---|
| Description | Sintilimab plus chemotherapy as first-line treatment for squamous non-small cell lung cancer (NSCLC) significantly prolonged progression-free survival (PFS) compared to chemotherapy (platimum and gemcitabine) alone in the ORIENT-12 study. High-quality RNA sequencing data of 282 baseline tumor samples was analyzed to explore efficacy-related biomarkers. |
| Organism | Homo sapiens |
| Data Type | Non-coding RNA Profiling |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA016762 |
| Release Date | 2024-12-31 |
| Submitter | li pu (pu.li@innoventbio.com) |
| Organization | Innovent Biologics (Suzhou) Co., Ltd. |
| Submission Date | 2023-05-06 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX003936-02 | cibi308C303RNA-1 | 282 | Non-coding RNA Profiling | 68.9 MB | xlsx | Unavailable |
| OMIX003936-03 | cibi308C303 RNA-2 | 282 | Non-coding RNA Profiling | 56.0 MB | xlsx | Unavailable |
| OMIX003936-03 | cibi308C303 RNA-2 | 282 | Non-coding RNA Profiling | 56.0 MB | xlsx | Unavailable |
| OMIX003936-03 | cibi308C303 RNA-2 | 282 | Non-coding RNA Profiling | 56.0 MB | xlsx | Unavailable |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|